Related Experiment Video
Updated: Jan 23, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
Published on: July 25, 2025
[Prognostic Value of CD14+HLA-DRlow/- Myeloid Derived Suppressor Cells in Diffuse Large B Cell Lymphoma]
Chen-Xin Wu1, Ming Qiang2, Ji-Qing Hao3
1Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, Anhui Province, China,Department of Oncology, The 901th Hospital of the Joint Logistics Support Force of PLA, Hefei 230031, Anhui Province, China.
Insights
Myeloid-derived suppressor cells (MDSC) are elevated in diffuse large B cell lymphoma (DLBCL) patients. Higher MDSC levels independently predict poorer overall survival in DLBCL.
Area of Science:
- Immunology
- Oncology
- Hematology
Background:
- Diffuse large B cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
- Understanding prognostic factors is crucial for optimizing patient management.
- The role of the tumor immune microenvironment in DLBCL prognosis requires further elucidation.
Purpose of the Study:
- To investigate the prognostic significance of myeloid-derived suppressor cells (MDSC) in patients with DLBCL.
- To determine if MDSC levels correlate with clinical parameters and survival outcomes in DLBCL.
Main Methods:
- Peripheral blood samples were collected from 52 DLBCL patients and 30 healthy controls.
- Myeloid-derived suppressor cells (MDSC) were identified using the immune marker CD14+HLA-DRlow/-.
- Correlation analysis was performed between MDSC levels and clinicopathological data, including staging, LDH, IPI score, and survival.
Main Results:
- MDSC proportions were significantly increased in newly diagnosed DLBCL patients compared to healthy volunteers (P<0.01).
- MDSC levels correlated with clinical staging, lactate dehydrogenase (LDH) levels, and International Prognostic Index (IPI) scores in DLBCL patients (P<0.01).
- Univariate and multivariate analyses identified IPI score and MDSC levels as independent risk factors for overall survival (OS) in DLBCL patients.
Conclusions:
- Myeloid-derived suppressor cells (MDSC) represent a significant independent prognostic factor for overall survival in DLBCL.
- MDSC levels can serve as a valuable biomarker for assessing the immune microenvironment and prognosis in DLBCL patients.
- These findings highlight the potential of targeting MDSC for therapeutic strategies in DLBCL.
Objective:
To investigate the role of myeloid-derived suppressor cells (MDSC) in the prognosis of patients with diffuse large B cell lymphoma (DLBCL).
Methods:
The peripheral blood of 52 DLBCL patients and 30 healthy volunteers was collected. The CD14+HLA-DRlow/- was used as the immune marker for MDSC. The role of MDSC in the prognosis of DLBCL patients was analyzed by combination with the related clinicopathological data.
Results:
The proportion of MDSC in peripheral blood of newly diagnosed DLBCL patients increased significantly (P<0.01). The expression of MDSC in DLBCL patients was related with clinical staging, lactate dehydrogenase (LDH) level and IPI score (P<0.01). There was no significant correlation with sex, age, and B symptoms. Univariate analysis showed that the clinical stage, serum LDH level, IPI score and MDSC level were the adverse factors affecting the overall survival (OS). Multivariate analysis showed that IPI score and MDSC level were independent risk factors for OS in DLBCL patients.
Conclusion:
MDSC can be used as an important index to evaluate the prognosis of DLBCL patients, contributing to evaluate the immune and tumor microenvironment of DLBCL patients.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Diffusion
Diffusion
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

